ALK Activation as a target of TRAanslational Science (ALKATRAS): Break free from cancer

Resultado final

Research articles will be published detailing the research findings from the ALKATRAS network

A series of review articles will be prepared and published in the scientific literature

A report will be prepared containing an overview of all outreach and dissemination activities carried out and achieved during the course of the ETN

ALCL transcriptome database

A database will be developed that details the transcriptome of ALCL. This will be available to the wider scientific community.

Therapies for resistant disease database

A database will be produced detailing therapies that can be used for the treatment of ALK-related cancers that are resistant to other forms of therapy

Therapy Synergism database

A database will be developed to aid clinicians in the treatment of patients with ALK-related malignancies. The database will detail those therapeutic compounds that have synergy

Mutations database

A database will be produced detailing somatic and acquired mutations in ALCL.

Epigenetics database

A database will be developed detailing deregulated cpG islands in ALK-related cancers which will be available to the wider scientific community

Podcasts

Students will produce podcasts detailing their research that will be accessible to teh general public and the scientific community.

ALKATRAS website developed and updated

An ALKATRAS website will be developed and continually updated

Outreach

Students will undertake outreach activities to present their research to the scientific community and the general public

Award of PhD degrees

All students would have been awarded their PhD degrees and this will be announced on the ALKATRAS website.

Publicaciones

The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL)

Autores: Ivonne Montes-Mojarro, Julia Steinhilber, Irina Bonzheim, Leticia Quintanilla-Martinez, Falko Fend
Publicado en: Cancers, Edición 10/4, 2018, Página(s) 107, ISSN 2072-6694
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers10040107

Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes

Autores: Geeta Sharma, Ines Mota, Luca Mologni, Enrico Patrucco, Carlo Gambacorti-Passerini, Roberto Chiarle
Publicado en: Cancers, Edición 10/3, 2018, Página(s) 62, ISSN 2072-6694
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers10030062

Treatment Options for Paediatric Anaplastic Large Cell Lymphoma (ALCL): Current Standard and beyond

Autores: Nina Prokoph, Hugo Larose, Megan Lim, G. Burke, Suzanne Turner
Publicado en: Cancers, Edición 10/4, 2018, Página(s) 99, ISSN 2072-6694
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers10040099

The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability

Autores: Cosimo Lobello, Vasilis Bikos, Andrea Janikova, Sarka Pospisilova
Publicado en: Cancers, Edición 10/3, 2018, Página(s) 64, ISSN 2072-6694
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers10030064

The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas

Autores: Ines Garces de los Fayos Alonso, Huan-Chang Liang, Suzanne Turner, Sabine Lagger, Olaf Merkel, Lukas Kenner
Publicado en: Cancers, Edición 10/4, 2018, Página(s) 93, ISSN 2072-6694
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers10040093

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma

Autores: Serena Stadler, Vijay Singh, Fabian Knörr, Christine Damm-Welk, Wilhelm Woessmann
Publicado en: Cancers, Edición 10/4, 2018, Página(s) 114, ISSN 2072-6694
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers10040114

Targeting Autophagy in ALK-Associated Cancers

Autores: Julie Frentzel, Domenico Sorrentino, Sylvie Giuriato
Publicado en: Cancers, Edición 9/12, 2017, Página(s) 161, ISSN 2072-6694
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers9120161

The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma

Autores: Nikolai Schleussner, Olaf Merkel, Mariantonia Costanza, Huan-Chang Liang, Franziska Hummel, Chiara Romagnani, Pawel Durek, Ioannis Anagnostopoulos, Michael Hummel, Korinna Jöhrens, Antonia Niedobitek, Patrick R. Griffin, Roberto Piva, Henrike L. Sczakiel, Wilhelm Woessmann, Christine Damm-Welk, Christian Hinze, Dagmar Stoiber, Bernd Gillissen, Suzanne D. Turner, Eva Kaergel, Linda von Hoff, Micha
Publicado en: Leukemia, Edición 32/9, 2018, Página(s) 1994-2007, ISSN 0887-6924
Editor: Nature Publishing Group
DOI: 10.1038/s41375-018-0045-9

Comment on “ALK is a therapeutic target for lethal sepsis”

Autores: Rafael B. Blasco, Enrico Patrucco, Ines Mota, Wei-Tien Tai, Roberto Chiarle
Publicado en: Science Translational Medicine, Edición 10/471, 2018, Página(s) eaar4321, ISSN 1946-6234
Editor: American Association for the Advancement of Science
DOI: 10.1126/scitranslmed.aar4321

Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma

Autores: Nicole Prutsch, Elisabeth Gurnhofer, Tobias Suske, Huan Chang Liang, Michaela Schlederer, Simone Roos, Lawren C. Wu, Ingrid Simonitsch-Klupp, Andrea Alvarez-Hernandez, Christoph Kornauth, Dario A. Leone, Jasmin Svinka, Robert Eferl, Tanja Limberger, Astrid Aufinger, Nitesh Shirsath, Peter Wolf, Thomas Hielscher, Fritz Aberger, Johannes Schmoellerl, Dagmar Stoiber, Birgit Strobl, Ulrich Jäger, Phi
Publicado en: Leukemia, Edición 33/3, 2019, Página(s) 696-709, ISSN 0887-6924
Editor: Nature Publishing Group
DOI: 10.1038/s41375-018-0239-1

Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Autores: Peng Liu, Liwei Zhao, Jonathan Pol, Sarah Levesque, Adriana Petrazzuolo, Christina Pfirschke, Camilla Engblom, Steffen Rickelt, Takahiro Yamazaki, Kristina Iribarren, Laura Senovilla, Lucillia Bezu, Erika Vacchelli, Valentina Sica, Andréa Melis, Tiffany Martin, Lin Xia, Heng Yang, Qingqing Li, Jinfeng Chen, Sylvère Durand, Fanny Aprahamian, Deborah Lefevre, Sophie Broutin, Angelo Paci, Amaury Bo
Publicado en: Nature Communications, Edición 10/1, 2019, ISSN 2041-1723
Editor: Nature Publishing Group
DOI: 10.1038/s41467-019-09838-y

Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma

Autores: Matteo Menotti, Chiara Ambrogio, Taek-Chin Cheong, Chiara Pighi, Ines Mota, Seth H. Cassel, Mara Compagno, Qi Wang, Riccardo Dall’Olio, Valerio G. Minero, Teresa Poggio, Geeta Geeta Sharma, Enrico Patrucco, Cristina Mastini, Ramesh Choudhari, Achille Pich, Alberto Zamo, Roberto Piva, Silvia Giliani, Luca Mologni, Clayton K. Collings, Cigall Kadoch, Carlo Gambacorti-Passerini, Luigi D. Notarangel
Publicado en: Nature Medicine, Edición 25/1, 2019, Página(s) 130-140, ISSN 1078-8956
Editor: Nature Publishing Group
DOI: 10.1038/s41591-018-0262-9

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Autores: Peng Liu, Liwei Zhao, Jonathan Pol, Sarah Levesque, Adriana Petrazzuolo, Christina Pfirschke, Camilla Engblom, Steffen Rickelt, Takahiro Yamazaki, Kristina Iribarren, Laura Senovilla, Lucillia Bezu, Erika Vacchelli, Valentina Sica, Andréa Melis, Tiffany Martin, Lin Xia, Heng Yang, Qingqing Li, Jinfeng Chen, Sylvère Durand, Fanny Aprahamian, Deborah Lefevre, Sophie Broutin, Angelo Paci, Amaury Bo
Publicado en: Nature Communications, Edición 10/1, 2019, ISSN 2041-1723
Editor: Nature Publishing Group
DOI: 10.1038/s41467-019-09415-3

Oncogenic JAK2 V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms

Autores: Alessandro Prestipino, Alica J. Emhardt, Konrad Aumann, David O’Sullivan, Sivahari P. Gorantla, Sandra Duquesne, Wolfgang Melchinger, Lukas Braun, Slavica Vuckovic, Melanie Boerries, Hauke Busch, Sebastian Halbach, Sandra Pennisi, Teresa Poggio, Petya Apostolova, Pia Veratti, Michael Hettich, Gabriele Niedermann, Mark Bartholomä, Khalid Shoumariyeh, Jonas S. Jutzi, Julius Wehrle, Christine Dier
Publicado en: Science Translational Medicine, Edición 10/429, 2018, Página(s) eaam7729, ISSN 1946-6234
Editor: American Association for the Advancement of Science
DOI: 10.1126/scitranslmed.aam7729

High activation of STAT5A drives peripheral T-cell lymphoma and leukemia

Autores: Barbara Maurer, Harini Nivarthi, Bettina Wingelhofer, Ha Thi Than Pham, Michaela Schlederer, Tobias Suske, Reinhard Grausenburger, Ana-Iris Schiefer, Michaela Prchal-Murphy, Doris Chen, Susanne Winkler, Olaf Merkel, Christoph Kornauth, Maximilian Hofbauer, Birgit Hochgatterer, Gregor Hoermann, Andrea Hoelbl-Kovacic, Jana Prochazkova, Cosimo Lobello, Abbarna A. Cumaraswamy, Johanna Latzka, Melitta
Publicado en: Haematologica, 2019, Página(s) haematol.2019.216986, ISSN 0390-6078
Editor: Ferrata Storti Foundation
DOI: 10.3324/haematol.2019.216986

Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells

Autores: Luca Mologni, Mariantonia Costanza, Geeta Geeta Sharma, Michela Viltadi, Luca Massimino, Stefania Citterio, Stefania Purgante, Hima Raman, Alessandra Pirola, Massimo Zucchetti, Rocco Piazza, Carlo Gambacorti-Passerini
Publicado en: Neoplasia, Edición 20/5, 2018, Página(s) 467-477, ISSN 1476-5586
Editor: Elsevier
DOI: 10.1016/j.neo.2018.02.009

NPM-ALK-reactive T-cell responses in children and adolescents with NPM-ALK positive anaplastic large cell lymphoma

Autores: Vijay Kumar Singh, Sebastian Werner, Simone Schwalm, Volker Lennerz, Stephanie Ruf, Serena Stadler, Holger Hackstein, Alfred Reiter, Thomas Wölfel, Christine Damm-Welk, Wilhelm Woessmann
Publicado en: OncoImmunology, Edición 8/9, 2019, Página(s) e1625688, ISSN 2162-402X
Editor: Taylor and Francis
DOI: 10.1080/2162402x.2019.1625688

An anaplastic cardiac large cell lymphoma: A case report and analysis of cardiac involvement in newly diagnosed non-Hodgkin’s lymphoma from the Czech Lymphoma Study Group (CLSG) database

Autores: Lobello C, Janikova A, Kren L, Hermanova M, Sprlakova-Pukova A, Krejci J, Pospisilova S, Pytlik R, Hamouzova M, Belada D, Prochazka V, Duras J, Mocikova H, Trneny M
Publicado en: Journal of Cancer Research & Therapy, Edición 5/10, 2017, Página(s) 66-71, ISSN 2052-4994
Editor: Noble Research
DOI: 10.14312/2052-4994.2017-13

Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways

Autores: Jimmy Van den Eynden, Ganesh Umapathy, Arghavan Ashouri, Diana Cervantes-Madrid, Joanna Szydzik, Kristina Ruuth, Jan Koster, Erik Larsson, Jikui Guan, Ruth H. Palmer, Bengt Hallberg
Publicado en: Science Signaling, Edición 11/557, 2018, Página(s) eaar5680, ISSN 1937-9145
Editor: American Association for the Advancement of Science
DOI: 10.1126/scisignal.aar5680

Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells

Autores: Diana Cervantes-Madrid, Joanna Szydzik, Dan Emil Lind, Marcus Borenäs, Mats Bemark, Jean Cui, Ruth Helen Palmer, Bengt Hallberg
Publicado en: Scientific Reports, Edición 9/1, 2019, ISSN 2045-2322
Editor: Nature Publishing Group
DOI: 10.1038/s41598-019-55060-7

Existence of reprogrammed lymphoma stem cells in a murine ALCL-like model

Autores: Stefanie Kreutmair, Cathrin Klingeberg, Teresa Poggio, Geoffroy Andrieux, Alexander Keller, Cornelius Miething, Marie Follo, Dietmar Pfeifer, Khalid Shoumariyeh, Claudia Lengerke, Irene Gonzalez-Menendez, Falko Fend, Robert Zeiser, Suzanne D. Turner, Leticia Quintanilla-Martinez, Melanie Boerries, Justus Duyster, Anna L. Illert
Publicado en: Leukemia, 2020, ISSN 0887-6924
Editor: Nature Publishing Group
DOI: 10.1038/s41375-020-0789-x

NPM1c alters FLT3-D835Y localization and signaling in acute myeloid leukemia

Autores: Alina Rudorf, Tony Andreas Müller, Cathrin Klingeberg, Stefanie Kreutmair, Teresa Poggio, Sivahari Prasad Gorantla, Tamina Rückert, Annette Schmitt-Graeff, Anina Gengenbacher, Peter Paschka, Claudia Baldus, Robert Zeiser, George S. Vassiliou, Allan Bradley, Justus Duyster, Anna Lena Illert
Publicado en: Blood, Edición 134/4, 2019, Página(s) 383-388, ISSN 0006-4971
Editor: American Society of Hematology
DOI: 10.1182/blood.2018883140

Current Immunotherapeutic Approaches in T Cell Non-Hodgkin Lymphomas

Autores: Teresa Poggio, Justus Duyster, Anna Illert
Publicado en: Cancers, Edición 10/9, 2018, Página(s) 339, ISSN 2072-6694
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers10090339

Proteomic Phosphosite Analysis Identified Crucial NPM-ALK-Mediated NIPA Serine and Threonine Residues

Autores: Anina Gengenbacher, Alina Müller-Rudorf, Teresa Poggio, Linda Gräßel, Veronica I. Dumit, Stefanie Kreutmair, Lena J. Lippert, Justus Duyster, Anna L. Illert
Publicado en: International Journal of Molecular Sciences, Edición 20/16, 2019, Página(s) 4060, ISSN 1422-0067
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms20164060

Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis

Autores: Ivonne A. Montes-Mojarro, Wook Youn Kim, Falko Fend, Leticia Quintanilla-Martinez
Publicado en: Seminars in Diagnostic Pathology, Edición 37/1, 2020, Página(s) 32-46, ISSN 0740-2570
Editor: W. B. Saunders Co., Ltd.
DOI: 10.1053/j.semdp.2019.12.004

EMMPRIN (CD147) is induced by C/EBPβ and is differentially expressed in ALK+ and ALK− anaplastic large-cell lymphoma

Autores: Janine Schmidt, Irina Bonzheim, Julia Steinhilber, Ivonne A Montes-Mojarro, Carlos Ortiz-Hidalgo, Wolfram Klapper, Falko Fend, Leticia Quintanilla-Martínez
Publicado en: Laboratory Investigation, Edición 97/9, 2017, Página(s) 1095-1102, ISSN 0023-6837
Editor: Nature Publishing Group
DOI: 10.1038/labinvest.2017.54

Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America

Autores: Ivonne A. Montes-Mojarro, Bo-Jung Chen, Ana F. Ramirez-Ibarguen, Carmen M. Quezada-Fiallos, Wendy B. Pérez-Báez, Daniela Dueñas, Sandro Casavilca-Zambrano, Marcela Ortiz-Mayor, Erica Rojas-Bilbao, Hernan García-Rivello, Maria F. Metrebian, Marina Narbaitz, Carlos Barrionuevo, Carmen Lome-Maldonado, Irina Bonzheim, Falko Fend, Julia Steinhilber, Leticia Quintanilla-Martinez
Publicado en: Modern Pathology, Edición 33/5, 2020, Página(s) 781-791, ISSN 0893-3952
Editor: Nature Publishing Group
DOI: 10.1038/s41379-019-0415-5

Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases

Autores: Wook Youn Kim, Ivonne A. Montes-Mojarro, Falko Fend, Leticia Quintanilla-Martinez
Publicado en: Frontiers in Pediatrics, Edición 7, 2019, ISSN 2296-2360
Editor: Frontiers
DOI: 10.3389/fped.2019.00071

A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib

Autores: Geeta G. Sharma, Diego Cortinovis, Francesco Agustoni, Giulia Arosio, Matteo Villa, Nicoletta Cordani, Paolo Bidoli, William H. Bisson, Fabio Pagni, Rocco Piazza, Carlo Gambacorti-Passerini, Luca Mologni
Publicado en: Journal of Thoracic Oncology, Edición 14/11, 2019, Página(s) e257-e259, ISSN 1556-0864
Editor: Lippincott Williams & Wilkins Ltd.
DOI: 10.1016/j.jtho.2019.06.028

We shall overcome (drug resistance) some day

Autores: Geeta G. Sharma, Luca Mologni
Publicado en: Oncotarget, Edición 10/2, 2019, Página(s) 84-85, ISSN 1949-2553
Editor: Impact Journals
DOI: 10.18632/oncotarget.26550

Lorlatinib Treatment Elicits Multiple On- and Off-Target Mechanisms of Resistance in ALK-Driven Cancer

Autores: Sara Redaelli, Monica Ceccon, Marina Zappa, Geeta G. Sharma, Cristina Mastini, Mario Mauri, Marion Nigoghossian, Luca Massimino, Nicoletta Cordani, Francesca Farina, Rocco Piazza, Carlo Gambacorti-Passerini, Luca Mologni
Publicado en: Cancer Research, Edición 78/24, 2018, Página(s) 6866-6880, ISSN 0008-5472
Editor: American Association for Cancer Research
DOI: 10.1158/0008-5472.can-18-1867

Resultado final

Publicaciones

Compartir esta página

Descargar